Tomela, K.; Pietrzak, B.; Galus, Ł.; Mackiewicz, J.; Schmidt, M.; Mackiewicz, A.A.; Kaczmarek, M.
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy. Cells 2023, 12, 789.
https://doi.org/10.3390/cells12050789
AMA Style
Tomela K, Pietrzak B, Galus Ł, Mackiewicz J, Schmidt M, Mackiewicz AA, Kaczmarek M.
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy. Cells. 2023; 12(5):789.
https://doi.org/10.3390/cells12050789
Chicago/Turabian Style
Tomela, Katarzyna, Bernadeta Pietrzak, Łukasz Galus, Jacek Mackiewicz, Marcin Schmidt, Andrzej Adam Mackiewicz, and Mariusz Kaczmarek.
2023. "Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy" Cells 12, no. 5: 789.
https://doi.org/10.3390/cells12050789
APA Style
Tomela, K., Pietrzak, B., Galus, Ł., Mackiewicz, J., Schmidt, M., Mackiewicz, A. A., & Kaczmarek, M.
(2023). Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy. Cells, 12(5), 789.
https://doi.org/10.3390/cells12050789
